Inclisiran lowers LDL cholesterol for up to one year


eMediNexus    20 November 2017

Inclisiran lowers low density lipoprotein LDL bad cholesterol for up to one year in patients with high cardiovascular risk and elevated LDL cholesterol according to results from the ORION 1 trial presented at the recent ESC Congress held in Barcelona Spain. Inclisiran is a first in class investigational drug that acts by turning off PCSK9 synthesis in the liver.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.